US2008058543A1PendingUtilityA1

Process for making chiral 1,4-disubstituted piperazines

Assignee: ZELDIS JOSEPHPriority: Mar 12, 2002Filed: Aug 8, 2007Published: Mar 6, 2008
Est. expiryMar 12, 2022(expired)· nominal 20-yr term from priority
C07D 319/18C07C 309/06C07C 229/12C07B 2200/07C07D 487/10A61P 25/00C07D 405/06C07D 405/10
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process for a stereoselective preparation of novel chiral nitrogen mustard derivatives useful in synthesizing optically active 1,4-disubstituted piperazines of formula: wherein R, Ar, and Q are defined as set forth herein, and intermediate compounds therefor. The 1,4-disubstituted piperazines act as 5HT1A receptor binding agents useful in the treatment of Central Nervous System (CNS) disorders.

Claims

exact text as granted — not AI-modified
1 . A compound of formula II  
       
         
           
           
               
               
           
         
       
       wherein R and R′ each independently represents a lower alkyl of C 1 -C 3 , and optical isomers and salts thereof.  
     
     
         2 . A compound according to  claim 1  wherein said salt is:  
       
         
           
           
               
               
           
         
       
     
     
         3 . A compound selected from the group consisting of 
 N,N-bis(2-chloroethyl)-(R)-alanine methyl ester, trifluoromethanesulfonate; and    N,N-bis(2-chloroethyl)-(R)-alanine ethyl ester, trifluoromethanesulfonate;    and the optical isomers thereof.

Join the waitlist — get patent alerts

Track US2008058543A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.